查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447713

遠距患者監護市場：按產品、應用和最終用戶劃分——到 2031 年的全球預測

Remote Patient Monitoring Market by Product ( ) Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 247 Pages | 訂單完成後即時交付

價格

預計到 2031 年，全球遠距病患監護市場將達到 1,168.4 億美元，2024 年至 2031 年的複合年增長率為 13.7%。

該報告基於全面的一手和二手研究以及對市場情景的詳細分析，提供了該行業的關鍵驅動因素、限制因素、挑戰和機會。 該市場的推動因素包括老年人口不斷增長、慢性病患病率上升、醫療保健專業人員短缺、人們越來越認識到RPM 的好處（例如便利性和改善患者治療效果）以及降低醫療成本的需求不斷增長。驅動因素包括政府的有利措施促進遠距患者監護。

此外，遠距醫療和遠距患者監護方面的技術進步、新興國家患者數量的增加、可穿戴設備的日益普及、感測器技術的進步以及人工智慧和RPM 的整合正在推動該市場的顯著增長。我們提供機會。 然而，對數據準確性和可靠性的擔憂、限制遠端患者監測技術使用的障礙（例如存取限制）以及患者技術素養較低正在限制市場成長。 此外，對資料安全和隱私的擔憂，以及由於需要額外的人員來管理 RPM 系統而增加的管理成本，都對市場構成了挑戰。

以產品來看，預計到2024年，監護設備領域將佔據遠距病患監護市場的最大份額。 此細分市場的重要份額是由於各種慢性病的盛行率不斷上升、老年人口不斷增加、有利的監管環境、感測器技術的技術進步、個人化醫療保健的需求不斷增長、監測設備的人為增長。這是由於以下因素智能與機器學習的融合。

從應用來看，糖尿病領域預計將在 2024 年佔據遠端患者監測市場的最大份額。 傳統上，糖尿病主要被認為是一種遺傳性疾病，但其迅速流行使其被認為是一種與生活方式相關的疾病。 這個細分市場的很大一部分是由於遠距醫療在糖尿病管理中的使用、糖尿病盛行率的增加以及監測糖尿病患者的需求增加等因素造成的。

從最終用戶來看，家庭醫療保健領域預計將在 2024 年佔據遠距患者監護市場的最大份額。 該細分市場的巨大市場份額是由家庭護理環境的日益轉變、老年人慢性病發病率的增加、醫療專業人員的短缺以及消費者對使用RPM工具監測慢性病的意識不斷增強等推動的。

對全球遠距病患監護市場區域狀況的詳細分析提供了五個關鍵區域的詳細定性和定量見解。 到2024年，預計北美將佔據全球遠距病患監護市場的最大份額，其次是歐洲、亞太地區、拉丁美洲以及中東和非洲。 亞太地區預計將成為全球遠距患者監護市場成長最快的地區。 這一增長主要是由醫療保健支出增加、老年人口不斷增長、慢性病患病率上升、消費者意識提高、個人可支配收入增加以及更大的目標人群推動的，從而支持了市場成長。

目錄

第1章簡介

第2章研究方法

第 3 章執行摘要

第 4 章市場洞察

  • 市場
  • 摘要
  • 影響市場成長的因素
    • 市場動態影響分析
    • 因素分析
  • 遠距病患監護市場的監管分析
    • 摘要
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東
  • 價格分析
  • 產業趨勢
    • 醫療保健從醫生主導轉向消費者主導
    • 人工智慧與遠距患者監護技術的集成
  • 波特五力分析

第 5 章遠距病患監護市場評估：按產品

  • 摘要
  • 監控設備
    • 監控設備：依功能分類
    • 監控設備：依類型
  • 軟體
  • 服務

第 6 章遠距病患監護市場評估：按應用

  • 摘要
  • 糖尿病
  • 心血管疾病
  • 神經系統疾病
  • 呼吸系統疾病
  • 腫瘤學
  • 其他應用

第 7 章遠距病患監護市場評估：按最終使用者劃分

  • 摘要
  • 居家照護設施
  • 長期照護設施
  • 醫院
  • 其他最終用戶

第 8 章遠距病患監護市場評估：按地區

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太地區其他地區
  • 拉丁美洲
  • 中東/非洲

第9章競爭分析

  • 摘要
  • 主要成長策略
  • 競爭基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 領先企業
    • 新興公司

第10章公司簡介

  • Medtronic plc
  • Koninklijke Philips N.V.
  • Omron Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Ge Healthcare Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Baxter International Inc.
  • Oracle Corporation
  • Dexcom, Inc.
  • VitalConnect, Inc.
  • Other Companies

第11章 附錄

Product Code: MRHC - 104658

Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]), Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders), End User-Global Forecast to 2031

The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.

Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM provide a significant growth opportunity for this market. However, data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are challenging factors in the market.

Among products, in 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market. The large share of this segment is attributed to factors such as the increasing prevalence of various chronic diseases, the rising elderly population, favorable regulatory scenarios, technological advancements in sensor technology, the rising demand for personalized healthcare, and the integration of artificial intelligence and machine learning in monitoring devices.

Among applications, in 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market. Diabetes was traditionally viewed as a predominantly inherited disease but is increasingly recognized as a lifestyle-related condition due to its rapid prevalence. The large share of the segment is due to factors such as the utilization of telehealth during diabetes management, the increasing prevalence of diabetes, and the increased need to monitor diabetic patients.

Among end users, in 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market. This segment's large market share is attributed to the growing shift towards home-care settings, the rise in chronic diseases among the elderly, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.

An in-depth analysis of the geographical scenario of the global remote patient monitoring market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global remote patient monitoring market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global remote patient monitoring market. This growth is primarily driven by the increasing healthcare expenditure, rising geriatric population, rising prevalence of chronic diseases, growing consumer awareness, increasing personal disposable incomes, and a large target population, thereby supporting the market growth.

The key players operating in the global remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).

Scope of the Report:

Remote Patient Monitoring Market Assessment-by Product

  • Monitoring Devices
    • Monitoring Devices, by Functionality
  • Blood Glucose Monitoring Devices
  • Cardiac Monitoring Devices
  • Neurological Monitoring Devices
  • Respiratory Monitoring Devices
  • Multiparameter Monitoring Devices
  • Blood Pressure Monitoring Devices
  • Fetal and Neonatal Monitoring Devices
  • Weight Monitoring Devices
  • Other Monitoring Devices

Note: Other monitoring devices include temperature monitors, brain monitoring (EEG), and prothrombin monitors.

    • Monitoring Devices, by Type
  • Wearable Monitoring Devices
  • Portable Monitoring Devices
  • Bench-top Monitoring Devices
  • Software
  • Services

Remote Patient Monitoring Market Assessment-by Application

  • Diabetes
  • Cardiovascular Diseases
  • Neurological Diseases
  • Respiratory Diseases
  • Oncology
  • Other Applications

Note: Other applications include maternity care, post-surgery monitoring, elderly care, medical adherence, and sleep monitoring.

Remote Patient Monitoring Market Assessment-by End User

  • Home-care Settings
  • Hospitals
  • Long-term Care Facilities
  • Other End Users

Note: Other end users include ambulatory care, healthcare payers, and clinical research organizations

Remote Patient Monitoring Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition And Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency And Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection And Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research / Interviews With Key Opinion Leaders of The Industry
  • 2.3. Market Sizing And Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions For The Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Remote Patient Monitoring Market: Regulatory Analysis
    • 4.3.1. Overview
    • 4.3.2. North America
      • 4.3.2.1. U.S.
      • 4.3.2.2. Canada
    • 4.3.3. Europe
    • 4.3.4. Asia-Pacific
      • 4.3.4.1. China
      • 4.3.4.2. Japan
      • 4.3.4.3. India
    • 4.3.5. Latin America
    • 4.3.6. Middle East
  • 4.4. Pricing Analysis
  • 4.5. Industry Trends
    • 4.5.1. Shift From Physician-Driven to Consumer-Driven Healthcare
    • 4.5.2. Integration of Artificial Intelligence With Remote Patient Monitoring Technologies
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Buyers
    • 4.6.2. Bargaining Power of Suppliers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition

5. Remote Patient Monitoring Market Assessment- by Product

  • 5.1. Overview
  • 5.2. Monitoring Devices
    • 5.2.1. Monitoring Devices, by Functionality
      • 5.2.1.1. Blood Glucose Monitoring Devices
      • 5.2.1.2. Cardiac Monitoring Devices
      • 5.2.1.3. Neurological Monitoring Devices
      • 5.2.1.4. Respiratory Monitoring Devices
      • 5.2.1.5. Multiparameter Monitoring Devices
      • 5.2.1.6. Blood Pressure Monitoring Devices
      • 5.2.1.7. Fetal And Neonatal Monitoring Devices
      • 5.2.1.8. Weight Monitoring Devices
      • 5.2.1.9. Other Monitoring Devices
    • 5.2.2. Monitoring Devices, by Type
      • 5.2.2.1. Wearable Monitoring Devices
      • 5.2.2.2. Portable Monitoring Devices
      • 5.2.2.3. Bench-Top Monitoring Devices
  • 5.3. Software
  • 5.4. Services

6. Remote Patient Monitoring Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Diabetes
  • 6.3. Cardiovascular Diseases
  • 6.4. Neurological Disorders
  • 6.5. Respiratory Diseases
  • 6.6. Oncology
  • 6.7. Other Applications

7. Remote Patient Monitoring Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Home-Care Settings
  • 7.3. Long-Term Care Facilities
  • 7.4. Hospitals
  • 7.5. Other End Users

8. Remote Patient Monitoring Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies

10. Company Profiles

  • 10.1. Medtronic plc
  • 10.2. Koninklijke Philips N.V.
  • 10.3. Omron Corporation
  • 10.4. Boston Scientific Corporation
  • 10.5. Abbott Laboratories
  • 10.6. Siemens Healthineers AG
  • 10.7. Ge Healthcare Technologies, Inc.
  • 10.8. F. Hoffmann-La Roche AG
  • 10.9. Baxter International Inc.
  • 10.10. Oracle Corporation
  • 10.11. Dexcom, Inc.
  • 10.12. VitalConnect, Inc.
  • 10.13. Other Companies

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports
  • Table 1 Population Aged 65 or Above, by Region, 2019 Vs. 2030 Vs. 2050 (In Million)
  • Table 2 Total Deaths Due to Parkinson's And Alzheimer's, by Country, 2010 Vs. 2019 Vs. 2020
  • Table 3 Total Deaths Due to Respiratory Disorders (Influenza, Pneumonia, COPD, Asthma), by Country, 2010 Vs. 2019 Vs. 2020
  • Table 4 Total Deaths Due to Circulatory System Diseases (Ischemic Heart Disease, Cerebrovascular Diseases), by Country, 2010 Vs. 2019 Vs. 2020
  • Table 5 Recent Technological Developments in Remote Patient Monitoring
  • Table 6 Physicians Per 1000 People, by Country, 2020
  • Table 7 Hospital Beds Per 1000 People, by Country, 2020
  • Table 8 Remote Patient Monitoring Devices: FDA Medical Device Classification
  • Table 9 China's Medical Device Classification Management System
  • Table 10 Saudi Arabia: Medical Device Classification System
  • Table 11 Remote Patient Monitoring Devices: Pricing Analysis
  • Table 12 Remote Patient Monitoring Services: Pricing Model
  • Table 13 Global Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 14 Global Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Remote Patient Monitoring Devices Market, by Functionality, 2022-2031 (USD Million)
  • Table 16 Number of People With Diabetes, by Region (2021 Vs. 2030) (In Thousands)
  • Table 17 Global Blood Glucose Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Some of The Examples of Wearable Cardiac Monitoring Devices
  • Table 19 Some of The Examples of Implantable Cardiac Monitoring Devices
  • Table 20 Global Cardiac Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Neurological Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Respiratory Monitoring Devices, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Multiparameter Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Blood Pressure Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Number of Childbirths Per Year (2020 Vs. 2030)
  • Table 26 Global Fetal And Neonatal Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Weight Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Other Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Remote Patient Monitoring Devices, by Type, 2022-2031 (USD Million)
  • Table 30 Innovative Wearable Remote Patient Monitoring Devices
  • Table 31 Global Wearable Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Portable Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Bench-Top Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Major Features of Remote Patient Monitoring Software
  • Table 35 Global Remote Patient Monitoring Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Types of Services Involved in Remote Patient Monitoring
  • Table 37 Trends in The Services Segment
  • Table 38 Global Remote Patient Monitoring Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 40 Some of The Companies Offering Remote Patient Monitoring For Diabetes
  • Table 41 Global Remote Patient Monitoring Market For Diabetes, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Some of The Companies Offering Remote Patient Monitoring For Cardiovascular Diseases
  • Table 43 Global Remote Patient Monitoring Market For Cardiovascular Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Burden of Neurological Conditions (Dalys Per 100,000 Population)
  • Table 45 Deaths Per 100,000 Population Due to Parkinson's Disease And Alzheimer
  • Table 46 Some of The Companies Offering Remote Patient Monitoring For Neurological Disorders
  • Table 47 Global Remote Patient Monitoring Market For Neurological Disorders, by Country/Region, 2022-2031 (USD Million)
  • Table 48 Some of The Companies Offering Remote Patient Monitoring For Respiratory Diseases
  • Table 49 Global Remote Patient Monitoring Market For Respiratory Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 50 Some of The Companies Offering Remote Patient Monitoring For Oncology
  • Table 51 Global Remote Patient Monitoring Market For Cancer, by Country/Region, 2022-2031 (USD Million)
  • Table 52 Some of The Companies Offering Remote Patient Monitoring For Other Applications
  • Table 53 Global Remote Patient Monitoring Market For Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 55 Global Remote Patient Monitoring Market For Home-Care Settings, by Country/Region, 2022-2031 (USD Million)
  • Table 56 Global Remote Patient Monitoring Market For Long-Term Care Facilities, by Country/Region, 2022-2031 (USD Million)
  • Table 57 Global Remote Patient Monitoring Market For Hospitals, by Country/Region, 2022-2031 (USD Million)
  • Table 58 Global Remote Patient Monitoring Market For Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 59 Global Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 60 North America: Remote Patient Monitoring Market, by Country, 2022-2031 (USD Million)
  • Table 61 North America: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 62 North America: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 63 North America: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 64 North America: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 65 North America: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 66 U.S.: Macro Indicators & Micro Indicators
  • Table 67 U.S.: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 68 U.S.: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 69 U.S.: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 70 U.S.: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 71 U.S.: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 72 Canada: Macroeconomic Indicators
  • Table 73 Canada: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 74 Canada: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 75 Canada: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 76 Canada: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 77 Canada: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 78 Europe: Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 79 Europe: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 80 Europe: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 81 Europe: Remote Patient Monitoring Market, by Type, 2022-2031 (USD Million)
  • Table 82 Europe: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 83 Europe: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 84 Germany: Macroeconomic Indicators
  • Table 85 Germany: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 86 Germany: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 87 Germany: Remote Patient Monitoring Devices, by Type, 2022-2031 (USD Million)
  • Table 88 Germany: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 89 Germany: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 90 U.K.: Prevalence of Various Chronic Conditions
  • Table 91 U.K.: Macroeconomic Indicators
  • Table 92 U.K.: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 93 U.K.: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 94 U.K.: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 95 U.K.: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 96 U.K.: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 97 France: Macroeconomic Indicators
  • Table 98 France: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 99 France: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 100 France: Remote Patient Monitoring Market, by Type, 2022-2031 (USD Million)
  • Table 101 France: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 102 France: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 103 Italy: Leading Causes of Deaths (2020)
  • Table 104 Italy: Macroeconomic Indicators
  • Table 105 Italy: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 106 Italy: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 107 Italy: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 108 Italy: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 109 Italy: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 110 Spain: Macroeconomic Indicators
  • Table 111 Spain: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 112 Spain: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 113 Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 114 Spain: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 115 Spain: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 116 Rest of Europe: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 117 Rest of Europe: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 118 Rest of Europe: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 119 Rest of Europe: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 120 Rest of Europe: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 121 Asia-Pacific: Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 122 Asia-Pacific: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 123 Asia-Pacific: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 124 Asia-Pacific: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 125 Asia-Pacific: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 126 Asia-Pacific: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 127 China: Macroeconomic Indicators
  • Table 128 China: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 129 China: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 130 China: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 131 China: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 132 China: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 133 Japan: Macroeconomic Indicators
  • Table 134 Japan: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 135 Japan: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 136 Japan: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 137 Japan: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 138 Japan: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 139 India: Macroeconomic Indicators
  • Table 140 India: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 141 India: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 142 India: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 143 India: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 144 India: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 145 Rest of Asia-Pacific: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 146 Rest of Asia-Pacific: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 147 Rest of Asia-Pacific: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 148 Rest of Asia-Pacific: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 149 Rest of Asia-Pacific: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 150 Latin America: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 151 Latin America: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 152 Latin America: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 153 Latin America: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 154 Latin America: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 155 Middle East & Africa: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 156 Middle East & Africa: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 157 Middle East & Africa: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 158 Middle East & Africa: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 159 Middle East & Africa: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 160 Recent Developments, by Company, 2020-2024
  • Table 161 Product Portfolio Analysis

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Remote Patient Monitoring Market Size, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Remote Patient Monitoring Market Size, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Remote Patient Monitoring Market Size, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Remote Patient Monitoring Market, by Geography
  • Figure 11 Impact Analysis of Market Dynamics
  • Figure 12 Global Estimated Number of New Cancer Cases, 2020-2040
  • Figure 13 Benefits of Remote Patient Monitoring
  • Figure 14 Global Prevalence of Diabetes in People Aged 20-79 Years, 2011-2045
  • Figure 15 USFDA Regulatory Pathways For Medical Devices
  • Figure 16 Eu Regulatory Pathway - IVDR 2017/746
  • Figure 17 China: Medical Device Classification And Pre-Market Requirements For IVD Devices
  • Figure 18 Advantages of AI Integration in Remote Patient Monitoring
  • Figure 19 Porter's Five Forces Analysis
  • Figure 20 Global Remote Patient Monitoring Market, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 21 Global Remote Patient Monitoring Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 22 Estimated Number of Cancer Cases (2020-2040)
  • Figure 23 Global Remote Patient Monitoring Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 24 Global Remote Patient Monitoring Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 25 North America: Remote Patient Monitoring Market Snapshot
  • Figure 26 Geriatric Population in Canada (2019-2050)
  • Figure 27 Europe: Remote Patient Monitoring Market Snapshot
  • Figure 28 Asia-Pacific: Remote Patient Monitoring Market Snapshot
  • Figure 29 China: Estimated Number of New Cancer Cases (2020-2040)
  • Figure 30 Japan: Percentage of Population Aged 65 And Above (2010-2030)
  • Figure 31 Key Growth Strategies Adopted by Leading Players, 2020-2023
  • Figure 32 Remote Patient Monitoring Market: Competitive Benchmarking by Region
  • Figure 33 Competitive Dashboard: Remote Patient Monitoring Market
  • Figure 34 Medtronic plc: Financial Overview (2022)
  • Figure 35 Koninklijke Philips N.V.: Financial Overview (2022)
  • Figure 36 OMRON Corporation: Financial Overview (2022)
  • Figure 37 Boston Scientific Corporation: Financial Overview (2022)
  • Figure 38 Abbott Laboratories: Financial Overview (2022)
  • Figure 39 Siemens Healthineers AG: Financial Overview (2022)
  • Figure 40 GE Healthcare Technologies, Inc.: Financial Overview (2023)
  • Figure 41 F. Hoffmann-La Roche AG: Financial Overview (2023)
  • Figure 42 Baxter International, Inc.: Financial Overview (2023)
  • Figure 43 Oracle Corporation: Financial Overview (2022)
  • Figure 44 DexCom, Inc.: Financial Overview (2023)